Fistula News and Research

RSS
A Fistula is an abnormal opening or passage between two organs or between an organ and the surface of the body. Fistulas may be caused by injury, infection, or inflammation, or may be created during surgery.
FDA approves novel stomach-draining device to treat obesity

FDA approves novel stomach-draining device to treat obesity

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Excess activation of LOX may play causative role in progression of cardiac failure

Excess activation of LOX may play causative role in progression of cardiac failure

TVA Medical announces results from multicenter clinical study of everlinQ endoAVF System

TVA Medical announces results from multicenter clinical study of everlinQ endoAVF System

Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

Study reveals how geography affects the survival of people with end-stage kidney disease

Study reveals how geography affects the survival of people with end-stage kidney disease

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

TVA Medical's novel hemodialysis access technique shows positive outcomes in clinical study

TVA Medical's novel hemodialysis access technique shows positive outcomes in clinical study

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

OTSC placement therapy is safe, effective for closure of gastrointestinal defects

OTSC placement therapy is safe, effective for closure of gastrointestinal defects

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

Patient goes on fishing trip after undergoing complex brain surgery

Patient goes on fishing trip after undergoing complex brain surgery

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

CT-guided IRE therapy offers safe, feasible primary local treatment for advanced pancreatic cancer

CT-guided IRE therapy offers safe, feasible primary local treatment for advanced pancreatic cancer

Edna Adan named inaugural recipient of Renfield Foundation Award for Global Women's Health

Edna Adan named inaugural recipient of Renfield Foundation Award for Global Women's Health

Loyola surgeon successfully performs operation on patient suffering from rare disorder

Loyola surgeon successfully performs operation on patient suffering from rare disorder

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer